Announced Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ophthalmic Diseases: In June 2021, the Company ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2021/08/05/2275980/0/en/Oyster-Point-Pharma-Reports-Second-Quarter-2021-Financial-Results-and-Recent-Business-Highlights.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHt-Om7V3aAJV30GyogJNfWQRWjTA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.